FDB (First Databank, Inc.)’s Post

💉 **New COVID-19 Shots May Get Approval This Week** 🦠 Updated mRNA vaccines from Moderna and Pfizer, designed to target the KP.2 variant, could receive approval as soon as this week, according to sources familiar with the matter. It's still uncertain whether Novavax's non-mRNA shot, aimed at the JN.1 strain, will be approved at the same time. If approved, these new vaccines would be available a few weeks earlier than last year's updates. #COVID19 #Vaccines #Moderna #Pfizer #Novavax #HealthNews #PandemicResponse

I read this article in another post and when I went back to share it... it was deleted from LinkedIn and from reactions in my profile. hmm, I wonder why? A peer reviewed study was conducted on efficacy of C19 vaccines and below are a few excerpts. Our taxes paid to government continue to fund advertising, production, and administration of these bio weapons under the banner of SAVING LIVES. For to long I've been silent... "This would mean 2 lives saved for roughly 100,000 injections of the Pfizer vaccine. However, there is a risk of 27 deaths per 100,000 doses of Pfizer shot." “To put these findings in perspective, the official Severe Adverse Effects (SAE) rate for other vaccines is only 1-2 per million,” the Jan. 24 study said. The 2020 analysis’ “estimate based on the Pfizer trial data (1,250 SAEs per million) exceeds this benchmark by at least 600-fold.” What do we do now?

FDA OKs Updated Novavax COVID Shot - Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain The FDA granted emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against hospitalization and death from circulating variants. [MedPageToday] The protein-based shot represents a non-mRNA option for the 2024-2025 season, and follows the agency's recent approvals and authorizations of the updated Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) vaccinesopens in a new tab or window. "The COVID-19 vaccines have had a tremendous positive impact on public health and vaccination continues to be the most effective method for COVID-19 prevention," said Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research in the announcement. More>https://lnkd.in/gxymXVQa #achieve #blackleadership #latinoleaders #vaccines #pandemic #covid #medicine #healthcare #publichealth #populationhealth #communityhealth

FDA OKs Updated Novavax COVID Shot - Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain The FDA granted emergency use authorization (EUA) for an updated Novavax COVID-19 vaccine to protect against hospitalization and death from circulating variants. [MedPageToday] The protein-based shot represents a non-mRNA option for the 2024-2025 season, and follows the agency's recent approvals and authorizations of the updated Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty) vaccinesopens in a new tab or window. "The COVID-19 vaccines have had a tremendous positive impact on public health and vaccination continues to be the most effective method for COVID-19 prevention," said Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research in the announcement. More>https://lnkd.in/gvFkXgPa #vaccines #pandemic #covid #medicine #healthcare #publichealth #populationhealth #communityhealth  

Covid-19 vaccines found to protect against long Covid A study has revealed that Covid-19 vaccines are effective in preventing long Covid, but the BioNTech/Pfizer vaccine provided better protection than ChAdOx1, developed by Oxford University/AstraZeneca. https://lnkd.in/eyq4jdZK #LongCovid #Covid19 #Vaccines

https://lnkd.in/dKUUQGu4 A MUST READ PAPER! NICE REVIEW! This narrative review provides a picture of the current status of development of seven CHIKV vaccine candidates undergoing clinical phase trials after screening 1138 studies and five news articles available on the databases. Judit Perez Gomez Enrique Chacon-Cruz #chikungunya #vaccines

COVID-19 Vaccine Workshop Sets Global Standard for Timely Updates Amid Evolving Virus Challenges A report from the International Coalition of Medicines Regulatory Authorities and the WHO highlights the need for regular updates to COVID-19 vaccines to address the evolving virus and new variants. The report emphasizes the importance of a global strategy for vaccine updates and the creation of a panel to standardize data requirements and enhance variant surveillance. Collaboration among stakeholders is necessary to ensure an adaptable and responsive vaccination strategy. The report also emphasizes the need for transparency in the vaccine update process. The workshop resulted in the establishment of a structured process for swift vaccine updates in collaboration with global regulators and the WHO. Regular interactions and meetings with vaccine manufacturers and stakeholders will continue to facilitate regulatory approvals and implementation of updated vaccines. For more details please click the link! https://lnkd.in/ddVJ9fcM #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

Stay safe this fall! Updated COVID-19 vaccines from Moderna, Pfizer, and a new one from Novavax are now FDA-approved. With recent case surges, it's crucial to protect yourself and others. Get the latest info and schedule your shot today! #COVID19 #VaccineUpdate

Interesting article highlights the crucial need for understanding and accurately predicting vaccine stability in rapid response situations, in addition to the development of thermostable vaccines.